Infectious diseases are a major driver of morbidity and mortality globally. Treatment of
malaria, tuberculosis and human immunodeficiency virus infection are particularly …

We are providing an update to our previously published review paper on inhaled
nanoparticles, thus updating with the most recent reports in the literature. The field of …

The field of nanotechnology may hold the promise of significant improvements in the health
and well being of patients, as well as in manufacturing technologies. The knowledge of this …

Over the past few decades, there has been a considerable research interest in drug
nanocrystal system as a pharmaceutical approach for poorly soluble drugs. At the beginning …

Used since ancient times especially for the local treatment of pulmonary diseases, lungs and
airways are a versatile target route for the administration of both local and systemic drugs …

Nanoparticles bring many benefits to pulmonary drug delivery applications, especially for
systemic delivery and drugs with poor solubility. They have recently been explored in …

Because of their unique physicochemical properties, engineered nanoparticles have the
potential to significantly impact respiratory research and medicine by means of improving …

One of the most common causes of illnesses in humans is from respiratory tract infections
caused by bacterial, viral or fungal pathogens. Inhaled anti-infective drugs are crucial for the …

Aerosolized delivery of antimicrobial agents is an attractive option for management of
pulmonary infections, as this is an ideal method of providing high local drug concentrations …

Background: The lung comprises an interesting route of administration not only for topical
drugs but also for systemically acting drugs. Over the last years, several models have been …